Characterization of Mammalian Ceramide Synthases

哺乳动物神经酰胺合成酶的表征

基本信息

项目摘要

DESCRIPTION (provided by applicant): Ceramides (Cer) are comprised of a sphingoid base and amide-linked fatty acid, and are the backbones of complex sphingolipids as well as modulators of vital cellular processes. In recent years, it has become evident that mammalian tissues contain many different subcategories of Cer, and that the enzymes that form these important compounds are highly selective with respect to the fatty acyl-CoA substrate, but their selectivities for the sphingoid base have not yet been fully defined. Therefore, the overall objective of this grant is to provide a more fundamental and complete understanding of Cer synthases (CerS), their roles in regulating sphingoid base and Cer metabolism, and functions of novel metabolites. A major goal of the research in this grant is to elucidate the pathways for the biosynthesis and turnover of two recently discovered 1-deoxy- and 1-desoxymethyl-sphingoid bases as the backbones, and some of their biological functions (Aim 1). These compounds are made when serine palmitoyltransferase utilizes alanine or glycine instead of serine, and at least one known disease-human sensory neuropathy type 1, HSN1--has been found to result from elevated production of 1-deoxysphinganine (present mainly as the downstream metabolite 1- deoxydihydroCer). Preliminary studies for this proposal have established that production of these alternative categories of sphingolipids is far more common than has been previously appreciated, and the factors that influence their biosynthesis will be identified. Characterization of the CerS will also establish which are responsible for production of particular Cer subspecies, structural features of the enzymes that account for this selectivity, and determine how their activity is influenced by formation of homo- and hetero- dimers (Aim 2). These studies will utilize "lipidomic" mass spectrometry for the sphingolipid analysis because this technology provides information about not only individual molecular subspecies but also for other branches and metabolites. Thus, Aim 3 of the proposal will evaluate "cross-talk" among the different branches and metabolites and provide a integrative explanation for why distinctive subspecies distributions are found in plasma and tissues. Since many of the subspecies of sphingoid bases and Cer have been implicated in inherited and acquired disease, these studies will provide the underlying map of Cer metabolism that will help these processes be understood, and assist in developing more rational strategies for intervention. PUBLIC HEALTH RELEVANCE: Ceramides are modulators of vital cellular processes and have been implicated in inherited and acquired disease. The proposed studies will provide a map of ceramide metabolism that will aid in the understanding of diseases that are caused by aberrant ceramide metabolism, and assist in developing more rational strategies for intervention.
描述(由申请人提供):神经酰胺(CER)由鞘脂碱和酰胺连接的脂肪酸组成,是复杂的鞘脂的骨架以及重要的细胞过程的调节剂。近年来,哺乳动物组织含有许多不同的CER子类别,并且形成这些重要化合物的酶相对于脂肪酰基-COA底物具有很高的选择性,但它们对脊体碱的选择尚未具有已完全定义。因此,这笔赠款的总体目标是提供对CER合成酶(CERS),它们在调节鞘脂碱和CER代谢中的作用以及新代谢物的功能的更基本和完整的理解。该赠款中该研究的主要目的是阐明两个最近发现的两个最近发现的1-脱氧和1-甲氧基甲基 - 闪细的碱的途径,作为骨架,以及它们的某些生物学功能(AIM 1)。当丝氨酸棕榈酰转移酶使用丙氨酸或甘氨酸而不是丝氨酸时,这些化合物是制成的,至少一种已知的疾病 - 人类感觉神经病1型1型HSN1-被发现是由于1-脱氧丙氨酸的产生而引起的(主要是下降代谢物的下属代谢物。 1-脱氧二氢位)。该提案的初步研究已经确定,这些替代类别的鞘脂的产生比以前所欣赏的要普遍得多,并且将确定影响其生物合成的因素。 CER的表征还将确定负责特定CER亚种的生产,解释这种选择性的酶的结构特征,并确定其活性如何受同型和异性二聚体形成的影响(AIM 2)。这些研究将利用“脂肪组”质谱法进行鞘脂分析,因为该技术不仅提供了有关单个分子亚种,而且提供其他分支和代谢物的信息。因此,该提案的目标3将评估不同分支和代谢产物之间的“跨对词”,并为为什么在血浆和组织中发现独特的亚种分布提供了综合解释。由于许多鞘类碱基和CER的亚种都与遗传和获得的疾病有关,因此这些研究将提供CER代谢的基本图,这些图将有助于理解这些过程,并有助于制定更合理的干预策略。 公共卫生相关性:神经酰胺是重要的细胞过程的调节剂,并且与遗传和获得的疾病有关。拟议的研究将提供有关神经酰胺代谢的地图,该图将有助于理解由异常神经酰胺代谢引起的疾病,并有助于制定更理性的干预策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALFRED Harrison MERRILL其他文献

ALFRED Harrison MERRILL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALFRED Harrison MERRILL', 18)}}的其他基金

INVESTIGATION OF 1-DEOXYDIHYDROCERAMIDE BIOSYNTHESIS BY MAMMALIAN CELLS
哺乳动物细胞 1-脱氧二氢神经酰胺生物合成的研究
  • 批准号:
    8365570
  • 财政年份:
    2011
  • 资助金额:
    $ 33.02万
  • 项目类别:
1-DEOXY-SPHINGOID BASE AND 1-DEOXYDIHYDROCER BIOSYNTHESIS IN MAMALS
哺乳动物中 1-脱氧-鞘氨醇碱和 1-脱氧二氢生物合成
  • 批准号:
    8170944
  • 财政年份:
    2010
  • 资助金额:
    $ 33.02万
  • 项目类别:
Chemoprevention via modulation of autophagy by sphingolipids
通过鞘脂调节自噬进行化学预防
  • 批准号:
    7860733
  • 财政年份:
    2009
  • 资助金额:
    $ 33.02万
  • 项目类别:
Chemoprevention via modulation of autophagy by sphingolipids
通过鞘脂调节自噬进行化学预防
  • 批准号:
    7590890
  • 财政年份:
    2009
  • 资助金额:
    $ 33.02万
  • 项目类别:
CELL SURFACE GLYCOSPHINGOLIPIDS SSEA-3 AND SSEA-4
细胞表面糖脂 SSEA-3 和 SSEA-4
  • 批准号:
    7722618
  • 财政年份:
    2008
  • 资助金额:
    $ 33.02万
  • 项目类别:
SPHINGOLIPID METABOLISM IN THE RETINA
视网膜中的鞘脂代谢
  • 批准号:
    7722638
  • 财政年份:
    2008
  • 资助金额:
    $ 33.02万
  • 项目类别:
CHARACTERIZATION OF (GLYCO)SPHINGOLIPIDS IN (EMBRYONIC) MOUSE CELLS
(胚胎)小鼠细胞中(糖基)鞘脂的表征
  • 批准号:
    7722614
  • 财政年份:
    2008
  • 资助金额:
    $ 33.02万
  • 项目类别:
Characterization of Mammalian Ceramide Synthases
哺乳动物神经酰胺合成酶的表征
  • 批准号:
    8655162
  • 财政年份:
    2007
  • 资助金额:
    $ 33.02万
  • 项目类别:
Characterization of Mammalian Ceramide Synthases
哺乳动物神经酰胺合成酶的表征
  • 批准号:
    8841741
  • 财政年份:
    2007
  • 资助金额:
    $ 33.02万
  • 项目类别:
Characterization of mammalian ceramide synthases
哺乳动物神经酰胺合酶的表征
  • 批准号:
    7857929
  • 财政年份:
    2007
  • 资助金额:
    $ 33.02万
  • 项目类别:

相似国自然基金

兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
  • 批准号:
    72302197
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
  • 批准号:
    72332003
  • 批准年份:
    2023
  • 资助金额:
    166 万元
  • 项目类别:
    重点项目
异常获利、捐赠与会计信息操纵:基于新冠疫情的准自然实验研究
  • 批准号:
    72372061
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
签字注册会计师动态配置问题研究:基于临阵换师视角
  • 批准号:
    72362023
  • 批准年份:
    2023
  • 资助金额:
    28 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Mechanistic Studies of Polyketide Synthases Enabled by Unnatural Amino Acids and Antibody Fragment Structural Tools
非天然氨基酸和抗体片段结构工具实现的聚酮化合物合成酶的机理研究
  • 批准号:
    10448409
  • 财政年份:
    2020
  • 资助金额:
    $ 33.02万
  • 项目类别:
Mechanistic Studies of Polyketide Synthases Enabled by Unnatural Amino Acids and Antibody Fragment Structural Tools
非天然氨基酸和抗体片段结构工具实现的聚酮化合物合成酶的机理研究
  • 批准号:
    10227676
  • 财政年份:
    2020
  • 资助金额:
    $ 33.02万
  • 项目类别:
Structure-function studies of the sterol transport protein, STARD4.
甾醇转运蛋白 STARD4 的结构功能研究。
  • 批准号:
    8838431
  • 财政年份:
    2015
  • 资助金额:
    $ 33.02万
  • 项目类别:
Developing Therapeutics against Giardia and Other Anaerobic Protozoa by Targeting Parasite Fatty Acyl-CoA Synthetase (ACS)
通过靶向寄生虫脂肪酰辅酶 A 合成酶 (ACS) 开发针对贾第鞭毛虫和其他厌氧原生动物的治疗方法
  • 批准号:
    9099754
  • 财政年份:
    2015
  • 资助金额:
    $ 33.02万
  • 项目类别:
Structure-function studies of the sterol transport protein, STARD4.
甾醇转运蛋白 STARD4 的结构功能研究。
  • 批准号:
    9058424
  • 财政年份:
    2015
  • 资助金额:
    $ 33.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了